These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 8244419)

  • 1. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
    Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
    Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new immunization protocol for the production of monoclonal antibodies specific for VL subgroups of human immunoglobulins.
    Goto T; Abe M; Kosaka M
    Tokushima J Exp Med; 1990 Dec; 37(3-4):89-96. PubMed ID: 2128783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologically defined V region subgroups of human lambda light chains.
    Solomon A; Weiss DT
    J Immunol; 1987 Aug; 139(3):824-30. PubMed ID: 3110284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
    Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.
    Davern S; Tang LX; Williams TK; Macy SD; Wall JS; Weiss DT; Solomon A
    Am J Clin Pathol; 2008 Nov; 130(5):702-11. PubMed ID: 18854262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable-region subgroup distribution among lambda-type immunoglobulins in normal human serum.
    Abe M; Ozaki S; Wolfenbarger D; deBram-Hart M; Weiss DT; Solomon A
    J Clin Lab Anal; 1994; 8(1):4-9. PubMed ID: 8164110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
    Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations in the variable region of the lambda 2 chain of M315 suppression of antibodies to the idiotype of M315.
    Sakato N; Azuma T; Fujio H
    Biken J; 1985 Dec; 28(3-4):51-8. PubMed ID: 2423068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
    Solomon A; Frangione B; Franklin EC
    J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the antigenic structure of human immunoglobulin lambda-chain using monoclonal antibodies].
    Arsen'eva EL; Bogacheva GT; Solomon A; Weiss D; Ibragimov AR; Rokhlin OV
    Mol Biol (Mosk); 1990; 24(1):117-26. PubMed ID: 1693412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic and chemical differentiation of human lambda III light chain variable regions.
    Eulitz M; Murphy C; Weiss DT; Solomon A
    J Immunol; 1991 May; 146(9):3091-6. PubMed ID: 1901892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
    Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and serologic characterization of human lambda VIII light chains.
    Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
    J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
    Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
    Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region.
    Bogen B; Jørgensen T; Hannestad K
    Eur J Immunol; 1985 Mar; 15(3):278-81. PubMed ID: 2579823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies specific for variable and constant domains of murine lambda chains.
    Bogen B
    Scand J Immunol; 1989 Mar; 29(3):273-9. PubMed ID: 2497510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.